<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: NORTHSTRIVE FUND II LP -->
          <cik>0002099270</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, $0.00001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>02/10/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001661053</issuerCik>
        <issuerName>enVVeno Medical Corp</issuerName>
        <issuerCusip>29415J205</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>70 Doppler</com:street1>
          <com:city>Irvine</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92618</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Northstrive Fund II LP</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>20129.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>20129.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>20129.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>3.07</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 20,129 shares beneficially owned by Northstrive Fund II LP, out of 655,606 shares of enVVeno Medical Corporation ("Issuer")'s issued and outstanding shares of common stock, par value $0.00001 per share ("Common Stock") on January 20, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission ("Commission") on January 20, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Braeden Lichti</reportingPersonName>
      <citizenshipOrOrganization>Z4</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>13022.00</soleVotingPower>
        <sharedVotingPower>20129.00</sharedVotingPower>
        <soleDispositivePower>13022.00</soleDispositivePower>
        <sharedDispositivePower>20129.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>33151.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.05</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 33,151 shares of enVVeno Medical Corporation ("Issuer") beneficially owned by Mr. Lichti, out of 655,606 shares of the Issuer's issued and outstanding shares of Common Stock on January 20, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the Commission on January 20, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>enVVeno Medical Corp</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>70 Doppler Irvine, CA 92618</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed by: (i) Northstrive Fund II LP; and (ii) Braeden Lichti ("Mr. Lichti"). The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>120 Newport Center Drive, Suite 250 Newport Beach, CA 92660</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Northstrive Fund II LP is a Delaware corporation. Mr. Lichti is a citizen of Canada.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The information required by Item 4(a) is set forth in Rows 5-11 of the cover page for each Reporting Person and is incorporated herein by reference for each Reporting Person.</amountBeneficiallyOwned>
        <classPercent>Braeden Lichti: 5.05% Northstrive Fund II LP: 3.07%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Northstrive Fund II LP: 0 Braeden Lichti: 13,022</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Northstrive Fund II LP: 20,129 Braeden Lichti: 20,129</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Northstrive Fund II LP: 0 Braeden Lichti: 13,022</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Northstrive Fund II LP: 20,129 Braeden Lichti: 20,129</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Northstrive Fund II LP</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Braeden Lichti</signature>
        <title>Braeden Lichti, Manager</title>
        <date>02/10/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Braeden Lichti</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Braeden Lichti</signature>
        <title>Braeden Lichti</title>
        <date>02/10/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
